Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
about
Ventral Tegmental Area Afferents and Drug-Dependent BehaviorsPresynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?SHANK3 controls maturation of social reward circuits in the VTAThe serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Design and construction of a low-cost nose poke system for rodentsLinking Cholinergic Interneurons, Synaptic Plasticity, and Behavior during the Extinction of a Cocaine-Context Association.Increased expression of proenkephalin and prodynorphin mRNAs in the nucleus accumbens of compulsive methamphetamine taking rats.Punishment of alcohol-reinforced responding in alcohol preferring P rats reveals a bimodal population: Implications for models of compulsive drug seeking.Alterations in Striatal Circuits Underlying Addiction-Like Behaviors.Modeling the development of drug addiction in male and female animals.Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.Associative and sensorimotor cortico-basal ganglia circuit roles in effects of abused drugs.Ventral tegmental area subcircuits process rewarding and aversive experiences.Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.Reward Circuitry in Addiction.From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.Viral strategies for targeting cortical circuits that control cocaine-taking and cocaine-seeking in rodents.Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons.Distinct Ventral Pallidal Neural Populations Mediate Separate Symptoms of Depression.Role of dopamine projections from ventral tegmental area to nucleus accumbens and medial prefrontal cortex in reinforcement behaviors assessed using optogenetic manipulation.The Ventral Pallidum: Proposed Integrator of Positive and Negative Factors in Cocaine Abuse.Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease.Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens.Limiting habenular hyperactivity ameliorates maternal separation-driven depressive-like symptoms.Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry.Kappa Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.Corticostriatal plasticity, neuronal ensembles, and regulation of drug-seeking behavior.Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.Different functional domains measured by cocaine self-administration under the progressive-ratio and punishment schedules in male Wistar rats.Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields.Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.Charcot, Mitchell and Lees: neurology free thinkers and their experiences of psychoactive drugs.[Mesolimbic dopamine neuron stimulation is sufficient for the progression to addiction].Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease.Overexpression of Thioredoxin-1 Blocks Morphine-Induced Conditioned Place Preference Through Regulating the Interaction of γ-Aminobutyric Acid and Dopamine Systems.Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio
P2860
Q26751118-848B9600-5DB9-418F-A215-B9825C5610A9Q28078759-23566208-0E66-40A2-9CC9-10FA09FB1A4DQ30786240-ACA22512-3098-43BE-B507-9EC330021DC5Q34546304-F0AB57FB-AD3C-4807-8C1C-68C6913573C7Q36028862-1BBF0EBF-05BA-4A12-9A4B-0E21C4DBA549Q36969385-7008B6CC-CC88-408A-9353-8FCAA58894E4Q37412033-4CC043BE-B58A-494C-9C05-1174C126E0CAQ38654592-BF019769-BFE7-4144-94C9-A68D2EC39FA4Q38655039-CF24463E-6C86-4618-A23B-B9A47672F51BQ38669858-230468A3-403D-47E3-82D7-2B8E4B3A467DQ38737932-222F21D4-3E45-42E8-9009-9A535852A202Q38908406-5646E2A0-A89C-417A-B5E1-89AAA72041B6Q38933453-60045357-FCCE-49D3-BC70-226FA211FBC7Q38990044-A8F0F215-89F4-49D5-A3D6-818D870BF714Q39190673-7DEAA10E-0059-4765-8F1F-DFDE0B8BFA80Q39301735-08CADB70-6A58-4289-8C8B-E9E145A711E2Q39335378-D5E432D0-A86D-43A7-A390-A9B1B4E9302CQ39497803-41DF6D38-6F99-4BCB-88A4-953C4BA9C69DQ40130435-95D77EF8-CD08-4010-BBED-B85E9C247E0AQ40195453-7DB9435D-4873-4C6D-A5F6-41CDAA355077Q40464344-3E400AC4-9868-4B98-945C-58F4207EAA4EQ41334077-237AF1E5-B87C-4B9B-BD4C-1D0BDB4EA28FQ41385264-810CDF52-E41E-4000-B038-FF1BFD0A7EE6Q42621237-8EAE2B5E-7552-4965-ACE8-6AA17644F4ABQ43847144-FA1E8EE6-9628-4363-9D57-85E1A64FEA87Q44346829-617825AC-7153-4422-8F05-41D021EBB538Q46011393-F03855B0-C332-4049-A25D-08A9D2EB17E2Q47178205-7496D533-AE30-4682-B8F6-1FA7658DBCA0Q47302967-BB5F114A-7F22-45D4-8BFA-42C8DF4E6CFDQ47315933-891FF7F8-075C-43FD-8627-F07D7E087A75Q47445865-06FF25D1-B437-4D36-ABAC-14818420855CQ47550488-E7A5AFFB-5CB7-452D-8B61-58971ECB85B6Q47602804-191F5E97-6153-4A24-B62C-1B5511482EEBQ52310610-46B51843-B8CF-4499-976C-A5B8204A496EQ52677022-C0BCC6C0-56FA-4D12-9C00-73BCB31A4E68Q55027526-1B77D806-5564-4803-97B8-EDF2B1DEA0A2Q58694142-D4388EA3-8BCE-4EFB-9FEB-12EA8588CBAB
P2860
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@en
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@nl
type
label
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@en
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@nl
prefLabel
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@en
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@nl
P2093
P1433
P1476
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.
@en
P2093
Agnès Hiver
Jean Terrier
Vincent Pascoli
P304
P356
10.1016/J.NEURON.2015.10.017
P407
P577
2015-11-11T00:00:00Z